{"version":"1.0","provider_name":"Instituto Interuniversitario de Reconocimiento Molecular y Desarollo Tecnol\u00f3gico","provider_url":"https:\/\/idm-instituto.webs.upv.es\/wordpress","author_name":"Jordi Hern\u00e1ndez","author_url":"https:\/\/idm-instituto.webs.upv.es\/wordpress\/index.php\/author\/jhercon\/","title":"Biocancer Group at ISLB 2026 &#8211; Instituto Interuniversitario de Reconocimiento Molecular y Desarollo Tecnol\u00f3gico","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"65oe9aL5XA\"><a href=\"https:\/\/idm-instituto.webs.upv.es\/wordpress\/index.php\/2026\/11\/09\/biocancer-group-at-islb-2026\/\">Biocancer Group at ISLB 2026<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/idm-instituto.webs.upv.es\/wordpress\/index.php\/2026\/11\/09\/biocancer-group-at-islb-2026\/embed\/#?secret=65oe9aL5XA\" width=\"600\" height=\"338\" title=\"&#8220;Biocancer Group at ISLB 2026&#8221; &#8212; Instituto Interuniversitario de Reconocimiento Molecular y Desarollo Tecnol\u00f3gico\" data-secret=\"65oe9aL5XA\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/idm-instituto.webs.upv.es\/wordpress\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/idm-instituto.webs.upv.es\/wordpress\/wp-content\/uploads\/2026\/11\/eloisa-mesaredonda.jpeg","thumbnail_width":1280,"thumbnail_height":960,"description":"Prof. Eloisa Jantus, Principal Investigator of the IDM\u2019s Biocancer Group, participated as an invited speaker at the 8th Annual Congress of the International Society of Liquid Biopsy (ISLB 2026), held in Madrid from 7 to 9 November. The meeting brought together international experts to present the latest advances in liquid biopsy, emerging technologies and their [&hellip;]"}